VERIF·AI
Sign in Run a check
Home › Companies › Other research and experimental... › Global Cancer Consultants Limited

Global Cancer Consultants Limited

Active ·SC415654 ·Private Limited Company ·Est. 27 January 2012
£854
Current Assets
2
Officers
Micro Entity
Accounts
⚠️
Initial checks flagged a potential issue. Further analysis recommended before making a decision.
CONFIRMED SIGNAL
Accounts filed late
3104 days overdue
Confirmed from Companies House data Period end 31 Jan 2017 · due 1 Nov 2017
Full analysis checks for Global Cancer Consultants Limited
  • 👤
    Director history and patterns Prior appointments, dissolved-company links, time-in-role across the cap table.
  • 📄
    Filing behaviour over time Lateness, restated accounts, confirmation-statement discipline across the last five years.
  • 📈
    Financial signals and trends Net assets, current liabilities, going-concern notes and year-on-year movement.
  • ✦
    Plain-English risk summary A clear paragraph telling you what these signals mean — and what to do about them.
Generated instantly from official filings and proprietary models.
🔒 Unlock the full report

Three ways to upgrade

If you check more than 2 companies a month, the £39 plan pays for itself.

  1. £99/mo · 30 Deep Dives Most popular
    £3.30 per report — the lowest rate
    Subscribe →
  2. £39/mo · 10 Deep Dives
    £3.90 per report — pays for itself after 2 reports
    Subscribe →
  3. £9 · 1 Deep Dive
    Single check, no subscription
    Buy £9 →

📊 Financial Snapshot — 31 January 2017

£854
Current Assets
-£644
Equity
201720162015
Cash—£4,702—
Source: Companies House filed accounts · Deep Dive: ratios, 10-year trends & AI analysis →

🏢 Company Details

NumberSC415654
StatusActive
TypePrivate Limited Company
Incorporated27 January 2012
IndustryOther research and experimental development on natural sciences and engineering
SIC72190
AccountsMicro Entity

📍 Registered Address

C/O Douglas Mcdonald Ca
Kilmacolm
Renfrewshire
PA13 4AE
United Kingdom

👤 Directors & Officers (2)

Prof Nicholas Barrie La ThangueDIRECTOR
La ThangueDIRECTOR

🔑 Persons with Significant Control (1)

Prof Nicholas Barrie La Thangue75-100% shares

🏗️ Corporate Group & Network

🔗 5 connected companies
Other companies sharing the same PSC
Celleron Therapeutics Limitedvia Prof Nicholas Barrie La Thangue 13423828via Prof Nicholas Barrie La Thangue Argonaut Therapeutics Limitedvia Prof Nicholas Barrie La Thangue Ingenox Therapeutics Limitedvia Prof Nicholas Barrie La Thangue Canivax Limitedvia Prof Nicholas Barrie La Thangue
Network data from Companies House PSC register · Full network analysis in Deep Dive →
Health Score
73
Revenue Trend
Risk Signals
🔒

AI Intelligence Report

Health score, risk analysis, compliance & sanctions screening

Go Deeper on Global Cancer Consultants Limited

Our AI reads their filings so you don't have to — full balance sheet & P&L analysis, health score, director network intelligence, FCDO sanctions screening, and a narrative you can actually understand.

✓ Free · magic link login · ✓ AI-powered · ✓ Ready in ~2 min
10-Year Financials Health Score Risk Flags FCDO Sanctions PDF Export
Generate Deep Dive & Track Global Cancer...
Sign up and generate a Deep Dive for full AI analysis, ratios, trend charts and automatic filing alerts.
Run full company check — £9